In summary, this study elucidates the negative association of eGDR with ASCVD risk, and AIP, VAI, CMI, LAP, and BMI may partially mediate the negative association, advancing the importance of enhancing glucose utilization capability in lowering the risk of cardiovascular disease. The gene discussed is AIP; the disease is atherosclerosis.